Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million
12/05/2026 21:07
May 12 (Reuters) - Interpace Biosciences Q1 operating income USD 1.123 million. Q1 gross profit USD 5.904 million Q1 net income USD 721 thousand Q1 operating expenses USD 4.781 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million